Alberta immunization policy

Overview

Immunization is one of the most important public health measures used to protect the health of Albertans. It is one of the most successful and cost-effective public health interventions.

The Alberta Immunization Policy (AIP) contains a complete listing of publicly funded vaccines and biologicals, and indications for their use.

• The AIP is revised as new research and national recommendations become available –
  • always reference the current version
  • check this page regularly for updates
• Read the Canadian Immunization Guide for more information about immunization.
• Read Alberta’s routine immunization schedule

Legislation

• Public Health Act
• Immunization Regulation
  • requires health practitioners to report immunizations and assessments electronically to Alberta Health within a week – effective January 1, 2021
  • requires health practitioners to report adverse events following immunization to Alberta Health Services within 3 days of becoming aware – effective December 17, 2018
  • sets out requirements for the storage, handling and transportation of vaccines – effective December 17, 2018
• Read more about the immunization regulation
• Immunization reporting by electronic means

AIP documents

All current AIP documents are hosted on Open Alberta.

AIP updates

• Table of AIP Updates

Introduction to AIP

• Background
• Provincial Mandate
• Immunization Goals and Objectives
• Eligibility Criteria for Provincially Funded Vaccine
• Roles and Responsibilities
• Alberta Outreach Immunization Program

General principles

• Assessment Expected Prior to Vaccine Administration
• Biological Considerations
• Immunization of Individuals with Inadequate Immunization Records
• Occupational Immunization Considerations

History of immunization in Alberta

• Alberta immunization program changes

Immunization schedules

• Routine Childhood Immunization Schedule
• Adult Immunization Schedule
• Immunization of Individuals with Chronic Health Conditions or Medical Conditions

Biological products

Botulism

• Botulism Antitoxin Heptavalent (Equine) Types A to G

COVID-19

• COVID-19 vaccine – mRNA
• COVID-19 vaccine – non-mRNA

COVID-19 resources for health care practitioners

• Allergy Pathways

Diphtheria Antitoxin

• Diphtheria Antitoxin (equine)

DTaP-IPV-Hib

• Diphtheria-Tetanus-Acellular Pertussis-Polio-Haemophilus influenzae type b Conjugate Combined Vaccine

DTaP-IPV-Hib-HB

• Diphtheria-Tetanus-Acellular Pertussis-Hepatitis B-Polio-Haemophilus influenzae type b Conjugate Combined Vaccine

Ebola Vaccine

• Ebola Zaire Vaccine

HIB (Haemophilus influenzae type b)

• Haemophilus influenzae type b Conjugate Vaccine

Hepatitis A (HAV)

• Hepatitis A Vaccine

Hepatitis A and B (HABV)

• Hepatitis A and B Combined Vaccine

Hepatitis B (HBV)

• Hepatitis B Immune Globulin (Human)
• Hepatitis B Vaccine
• Hepatitis B Virus Infection – High Endemic Geographic Areas
• Hepatitis B Risk Assessment for Paid Workers/Volunteers/Students

HPV

• Human Papillomavirus Vaccine: HPV 9

Herpes Zoster

• Herpes Zoster - Shingrix Vaccine

Immune Globulin (IG)

• Immune Globulin (Human)

Influenza (Flu)

• Standard Dose Vaccines
• High Dose and Adjuvanted Vaccines
• Avian Influenza Vaccine (Not currently available)

MMR

• Measles-Mumps-Rubella Combined Vaccine

MMR-Varicella (MMR-Var)

• Measles-Mumps-Rubella-Varicella Combined Vaccine

Meningococcal

• Meningococcal B Multicomponent Recombinant Vaccine
• Meningococcal Conjugate (Groups A, C, Y and W-135)
• Meningococcal Conjugate C Vaccine

Mpox

• Smallpox and Mpox Vaccine

Pneumococcal

• Pneumococcal Vaccine, 15-valent Conjugate
• Pneumococcal Vaccine, 20-valent Conjugate

Polio

• Polio Vaccine

Rabies

• Rabies Immune Globulin (Human)
• Rabies Vaccine
• Rabies Post-exposure – Authorizing and Obtaining Rabies Post-exposure Biologicals

Respiratory Syncytial Virus (RSV)

• Respiratory Syncytial Virus Vaccine

Rotavirus

• Rotavirus Vaccine

Tdap

• Tetanus-Diphtheria-Acellular Pertussis Combined Vaccine
• Policy for pharmacists providing Tdap vaccine

Tdap-IPV

• Tetanus-Diphtheria-Acellular Pertussis-Polio Combined Vaccine

Tetanus

• Tetanus Immune Globulin (Human)
• Tetanus Post-exposure Prophylaxis in Injury/Wound Management

Tuberculin

• Tuberculin PPD

Typhoid

• Typhoid Vaccine

Varicella

• Varicella Vaccine
• Varicella Zoster Immune Globulin

Special situations for immunization

• Immunization Recommendations for Specific Populations (Immunosuppressed and Chronic Health Conditions)
• Hepatitis B (HBVD) Algorithm for Chronic Renal Disease

Immunization recommendations for transplant candidates and recipients

• Principles of Immunization in Hematopoietic Stem Cell Transplant (HSCT) and Solid Organ Transplant (SOT) Recipients
• Child HSCT
• Adult HSCT
• Child SOT (before 18 months of age)
• Child SOT (after 18 months of age)
• Adult SOT

Storage and handling

• Alberta Vaccine Storage and Handling Policy

Product problems

• Product Problem Policy
• Provincially Funded Vaccine Product Problems form

Adverse events following immunization

• Adverse Events Following Immunization (AEFI) Policy
• Report of Adverse Events Following Immunization form for Indigenous Services Canada
• Federal Vaccine Injury Support Program Information

Immunization data submission guidelines

• Immunization and Adverse Reactions Following Immunization – Permissible Values
• Immunization Batch Data Submission and Response Guidelines
• Adverse Events Following Immunization Data Submission and Response Guidelines

Contact

The email below is for health providers only. Health providers can connect with us for clarifications related to the Alberta Immunization Policy:

Email: [email protected]
Fax: 780-422-6663